COMPONENTS OF THE CARDIOVASCULAR HEALTH AND THEIR DYNAMICS OF LARGE INDUSTRIAL ENTERPRISES
https://doi.org/10.29001/2073-8552-2017-32-1-116-120
Abstract
Preventive examination of the employees of the Siberian Integrated Chemical Plant showed high frequency of risk factors for cardiovascular diseases (CVD) and poor cardiovascular health estimated using the model of ideal cardiovascular health. Ideal cardiovascular health, characterized by normal values of all major components, was not found in the surveyed workers cohort. Assessment of 10-year fatal risk with the SCORE scale provided a more optimistic prediction: low risk of death from CVD (<1%) was found in 12.3% of workers. Assessment of high-sensitivity C-reactive peptide and non-HDL cholesterol as criteria for effectiveness of health-promoting measures was non-informative in the present study. Therefore, the use of the ideal cardiovascular health model according to AHA allowed to identify abnormalities lost on the evaluation of total cardiovascular risk with the SCORE scale. Timely administration of health-promoting treatments to individuals of high-risk groups who has poor and moderate cardiovascular health allows to decrease the frequency and the severity of cardiovascular risk factors and to improve long-term prognosis of life.
About the Authors
A. V. Tonkoshkurova
Federal State Budgetary Institution “Siberian Federal Scientific Clinical Center of the Federal Medical-Biological Agency”
Russian Federation
Russian Federation
I. N. Smirnova
Tomsk Scientific Research Institute for Balneology and Physiotherapy” of Federal State Budgetary Institution “Siberian Federal Scientific Clinical Center of Federal Medicobiological Agency”
Russian Federation
Russian Federation
V. A. Vorobyov
Federal State Budgetary Institution “Siberian Federal Scientific Clinical Center of the Federal Medical-Biological Agency”
Russian Federation
Russian Federation
J. V. Semenova
Federal State Budgetary Institution “Siberian Federal Scientific Clinical Center of the Federal Medical-Biological Agency”
Russian Federation
Russian Federation
References
1. Аничков Д.А., Шостак Н.А. Новые маркеры сердечно-сосудистого риска: от исследований к клиническим рекомендациям // Клиницист. – 2014. – № 1. – С. 1–8.
2. Бойцов С.А., Шальнов С.А., Деев А.Д., Калинина А.М. Моделирование риска развития сердечно-сосудистых заболеваний и их осложнений на индивидуальном и групповом уровнях // Тер. архив. – 2013. – Т. 85, № 9. – С. 4–10.
3. Имаева А.Э., Шальнова С.А. Оценка сердечно-сосудистого риска: старые факторы – новая модель // Кардиоваск. терапия и профилактика. – 2015. – № 5. – С. 87–94.
4. Медицинские лабораторные технологии : cправочник / под ред. А.И. Карпищенко. – СПб. : Интермедика, 2002. – Т. 2. – 620 с.
5. Погосова Н.В., Юферева Ю.М., Самородская И.В., Бойцов С.А. Профилактический скрининг: все за и против // Кардиоваск. терапия и профилактика. – 2016. – № 3. – С. 4– 13.
6. Российские национальные рекомендации по кардиоваскулярной профилактике // Кардиоваск. терапия и профилактика. – 2011. – № 6, прил. 2. – С. 1–64.
7. Семенова Ю.В., Карпов А.Б., Литвиненко Т.М. и др. Контроль факторов риска сердечно-сосудистых заболеваний в реальной клинической практике // Врач. – 2014. – № 3. – С. 85– 87.
8. Cусеков А.В. Холестерин липопротеинов низкой плотности (ХС-ЛНП) и ремнантный холестерин неЛВП: нужна ли рокировка для оценки сердечно-сосудистого риска? // Мед. совет. – 2013. – № 9. – С. 50–55.
9. Тонкошкурова А.В., Смирнова И.Н., Воробьев В.А., Семенова Ю.В. Факторы риска сердечно-сосудистых заболеваний и уровень здоровья у работников атомной промышленности // Сиб. мед. журн. (Томск). – 2016. – № 2. – С. 128–132.
10. Goff D.C.Jr., Loyd-Jones D.M., Bennett G. et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines // J. Am. Coll. Cardiol. – 2014. –No. 63 (25 Pt B). – Р. 2935–2959.
11. Lloyd-Jones D.M., Hong Y., Labarthe D. et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Associations strategic Impact Goal through 2020 and beyond // Circulation. – 2010. – No. 121(4). – Р. 586–613.
12. Sniderman A., Williams K., Contoins J. et al. A meta-analysis of low density lipoprotein cholesterol, non-density lipoprotein cholesterol and apolipoprotein B as a markers of cardiovascular risk [Electronic resource] // Circ. Cardiovasc. Qual. Outcomes. – 2011. – No. 4(3). – P. 337–345. – Doi: 10.1161/CIRCOUTCOMES. 110. 959247. Epub. 2011, Apr. 12.
Review
For citations:
Tonkoshkurova A.V., Smirnova I.N., Vorobyov V.A., Semenova J.V. COMPONENTS OF THE CARDIOVASCULAR HEALTH AND THEIR DYNAMICS OF LARGE INDUSTRIAL ENTERPRISES. Siberian Journal of Clinical and Experimental Medicine. 2017;32(1):116-120. (In Russ.) https://doi.org/10.29001/2073-8552-2017-32-1-116-120
Views:
352
.png)
Email this article 